These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 36269541)

  • 21. Ocimum kilimandscharicum L. restores ovarian functions in letrozole - induced Polycystic Ovary Syndrome (PCOS) in rats: Comparison with metformin.
    Khaled N; El-Bahy AA; Radwan R; Handoussa H; AbdelMaksoud S
    Life Sci; 2019 Sep; 232():116640. PubMed ID: 31295470
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modulation of GABA by sodium butyrate ameliorates hypothalamic inflammation in experimental model of PCOS.
    Eepho OI; Bashir AM; Oniyide AA; Aturamu A; Owolabi OV; Ajadi IO; Fafure AA; Ajadi MB; Areloegbe SE; Olaniyi KS
    BMC Neurosci; 2023 Nov; 24(1):62. PubMed ID: 37996797
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of vitamin D on experimental model of polycystic ovary syndrome in female rats.
    Helal BAF; Ismail GM; Nassar SE; Zeid AAA
    Life Sci; 2021 Oct; 283():119558. PubMed ID: 33930367
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Therapeutic Efficacy of Melatonin Against Polycystic Ovary Syndrome (PCOS) Induced by Letrozole in Wistar Rat.
    Basheer M; Rai S; Ghosh H; Ahmad Hajam Y
    Pak J Biol Sci; 2018 Jan; 21(7):340-347. PubMed ID: 30417994
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ameliorative effects of fisetin in letrozole-induced rat model of polycystic ovary syndrome.
    Mihanfar A; Nouri M; Roshangar L; Khadem-Ansari MH
    J Steroid Biochem Mol Biol; 2021 Oct; 213():105954. PubMed ID: 34298098
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alleviative Effects of Adipose Tissue-derived Stem Cells and α-NETA on Metabolic, Biochemical, and Endocrine Parameters in a Letrozole-induced Rat Model of PCOS.
    Nejabati HR; Nikzad S; Roshangar L
    Curr Pharm Des; 2023; 29(24):1929-1938. PubMed ID: 37584355
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effects of thylakoid-rich spinach extract and aqueous extract of caraway (Carum carvi L.) in letrozole-induced polycystic ovarian syndrome rats.
    Sherafatmanesh S; Ekramzadeh M; Tanideh N; Golmakani MT; Koohpeyma F
    BMC Complement Med Ther; 2020 Aug; 20(1):249. PubMed ID: 32787839
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diacerein mitigates endocrine and cardio-metabolic disruptions in experimental PCOS mice model by modulating AdipoR1/ PON 1.
    Shah MZUH; Shrivastava VK; Muzamil S; Olaniyi KS
    BMC Endocr Disord; 2024 Jul; 24(1):109. PubMed ID: 38982395
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Therapeutic potentials of Quercetin in management of polycystic ovarian syndrome using Letrozole induced rat model: a histological and a biochemical study.
    Jahan S; Abid A; Khalid S; Afsar T; Qurat-Ul-Ain ; Shaheen G; Almajwal A; Razak S
    J Ovarian Res; 2018 Apr; 11(1):26. PubMed ID: 29615083
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Spironolactone reversed hepato-ovarian triglyceride accumulation caused by letrozole-induced polycystic ovarian syndrome: tissue uric acid-a familiar foe.
    Adeyanju OA; Falodun TO; Michael OS; Soetan OA; Oyewole AL; Agbana RD
    Naunyn Schmiedebergs Arch Pharmacol; 2020 Jun; 393(6):1055-1066. PubMed ID: 31925474
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Low-dose spironolactone combats dyslipidemia and hepatic inflammation by modulating PCSK9 in rat model of polycystic ovarian syndrome.
    Olaniyi KS; Areloegbe SE; Areola ED; Sabinari IW; Fafure AA; Agbana RD; Atuma CL; Shah MZUH; Ajadi IO; Olatunji LA
    Toxicol Appl Pharmacol; 2023 Aug; 473():116604. PubMed ID: 37328115
    [TBL] [Abstract][Full Text] [Related]  

  • 32.
    Noubouossie Pouegue J; Mvondo MA
    J Complement Integr Med; 2023 Jun; 20(2):379-386. PubMed ID: 36617954
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Very low dose spironolactone protects experimentally-induced polycystic ovarian syndrome from insulin-resistant metabolic disturbances by suppressing elevated circulating testosterone.
    Adeyanju OA; Falodun TO; Fabunmi OA; Olatunji LA; Soladoye AO
    Chem Biol Interact; 2019 Sep; 310():108742. PubMed ID: 31295448
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Therapeutic potential of sodium selenite in letrozole induced polycystic ovary syndrome rat model: Targeting mitochondrial approach (selenium in PCOS).
    Atef MM; Abd-Ellatif RN; Emam MN; Abo El Gheit RE; Amer AI; Hafez YM
    Arch Biochem Biophys; 2019 Aug; 671():245-254. PubMed ID: 31251923
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of anti-Müllerian hormone in letrozole rat model of polycystic ovary syndrome.
    Du DF; Li XL; Fang F; Du MR
    Gynecol Endocrinol; 2014; 30(12):885-9. PubMed ID: 25170777
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Altered vitamin D
    Grzesiak M; Burzawa G; Kurowska P; Blaszczyk K; Szlaga A; Blasiak A; Sechman A; Rak A
    Histochem Cell Biol; 2021 Jan; 155(1):101-116. PubMed ID: 33095902
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Soy isoflavones alleviate polycystic ovary syndrome in rats by regulating NF- κB signaling pathway.
    Ma X; Li X; Ma L; Chen Y; He S
    Bioengineered; 2021 Dec; 12(1):7215-7223. PubMed ID: 34546841
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel promising reproductive and metabolic effects of Cicer arietinum L. extract on letrozole induced polycystic ovary syndrome in rat model.
    Ali SE; El Badawy SA; Elmosalamy SH; Emam SR; Azouz AA; Galal MK; Abd-Elsalam RM; Issa MY; Hassan BB
    J Ethnopharmacol; 2021 Oct; 278():114318. PubMed ID: 34111539
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Therapeutic potential of quercetin in an animal model of PCOS: Possible involvement of AMPK/SIRT-1 axis.
    Mihanfar A; Nouri M; Roshangar L; Khadem-Ansari MH
    Eur J Pharmacol; 2021 Jun; 900():174062. PubMed ID: 33798596
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acetate mitigates cardiac mitochondrial dysfunction in experimental model of polycystic ovarian syndrome by modulating GPCR41/43 and PROKR1.
    Areloegbe SE; Olaniyi KS
    Biochem Biophys Res Commun; 2023 Nov; 681():62-72. PubMed ID: 37757668
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.